Q1 2025 Earnings Call Transcript April 29, 2025 NeoGenomics, Inc. misses on earnings expectations. Reported EPS is $-0.20352 ...

NeoGenomics (NASDAQ:NEO) shares plunged on Tuesday after the cancer lab operator reported lower-than-expected revenue for Q1 ...

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 34.8% in the afternoon session after the ...

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) in Q1 CY2025, but sales rose 7.5% year on year to $168 million ...

NeoGenomics shares dropped 34% on April 29 after missing its Q1 revenue estimates. Check out why I view the stock price ...

NeoGenomics (NEO) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.02 per share a year ago. These figures are ...

NeoGenomics (NASDAQ:NEO) is preparing to release its quarterly earnings on Tuesday, 2025-04-29. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting earnings tomorrow morning. Here’s what ...

NeoGenomics Inc (NEO) reports an 8% revenue increase and strategic advancements, despite challenges in the non-clinical sector.

NeoGenomics, Inc.’s NEO share price has dipped by 19.36%, which has investors questioning if this is right time to buy.